Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Lose weight with 24/7 support and ongoing care Step 3 Well be with you every step of the way, with regular check-ins and on-demand medical support
In a randomized, single-blind, 24-week study, participants assigned to dual therapy of 2 mg weekly of the GLP-1 receptor agonist exenatide (Bydureon, AstraZeneca) and 10 mg daily of the SGLT2 inhibitor dapagliflozin (Farxiga, AstraZeneca) lost more weight than those taking either agent alone or those receiving dapagliflozin and metformin extended-release (Xigduo XL, AstraZeneca) or phentermine/topiramate extended-release (Qsymia, Vivus)
Most people begin to see results after increasing to 7mg or 14mg daily, typically after four weeks
Topical options such as minoxidil can help extend the anagen phase and improve density over time
